title: How does current diabetes care compare with landmark clinical studies?
authors.affiliation: National Cardiovascular Intelligence Network, Public Health England, York.|Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow.
authors.forename: N
authors.initials: N
authors.lastname: Holman
authors.affiliation: Warwick Medical School, University of Warwick, Warwick.
authors.forename: R
authors.initials: R
authors.lastname: Gadsby
authors.affiliation: Clinical Audit, Health and Social Care Information Centre, Leeds, UK.
authors.forename: L
authors.initials: L
authors.lastname: Dunn
authors.affiliation: Clinical Audit, Health and Social Care Information Centre, Leeds, UK.
authors.forename: C
authors.initials: C
authors.lastname: Sylvester
authors.affiliation: National Cardiovascular Intelligence Network, Public Health England, York.|Salford Royal Foundation Trust, Salford, UK.
authors.forename: B
authors.initials: B
authors.lastname: Young
mesh_terms: D000140:Acidosis, Lactic / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005919:Glomerular Filtration Rate; D019983:Guideline Adherence; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007676:Kidney Failure, Chronic / Q000097:blood*; D008687:Metformin / Q000008:administration & dosage*
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin